These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7933789

  • 1. [Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy].
    Metelitsa VI, Duda SG, Ostrovskaia TP, Malysheva NV, Lerman OV, Shastun RS, Manoshkina EM, Piotrovskiĭ VK, Rumiantsev DO, Belolipetskaia VG.
    Kardiologiia; 1993; 33(4):32-8. PubMed ID: 7933789
    [Abstract] [Full Text] [Related]

  • 2. [Pharmaco -- genetic approach to the improvement of beta-adrenoblocker therapy in the treatment of hypertension].
    Filippenko NG, Povetkin SV, Smirnova II, Dementéva NG, Bredikhin VT.
    Kardiologiia; 1993; 33(5):30-2. PubMed ID: 7967324
    [Abstract] [Full Text] [Related]

  • 3. Acute hemodynamic effects of acebutolol and propranolol.
    Nigri A, Mangieri E, Martuscelli E, Reale A.
    Clin Ther; 1984; 6(5):693-8. PubMed ID: 6478471
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH, Man in 't Veld AJ, van Eck HJ, Boomsma F, Schalekamp MA.
    Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the acute effects of acebutolol and propranolol on blood pressure, heart rate and hormonal changes during graded treadmill exercise in patients with essential hypertension.
    Matsuura H, Masaoka S, Kanazawa I, Murano S, Tsuchioka Y, Kajiyama G.
    Jpn J Med; 1989 Oct; 28(1):8-15. PubMed ID: 2657144
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH, Man in't Veld AJ, Boomsma F, Fischberg DJ, Molinoff PB, Schalekamp MA.
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [Abstract] [Full Text] [Related]

  • 7. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
    Metelitsa VI, Duda SG, Gorbunov VM, Buchner-Moll D, Deev AD, Vygodin VA, Filatova NP, Chel'dieva EIa, Shastun RS, Simonov DV.
    Eksp Klin Farmakol; 1995 Oct; 58(2):32-4. PubMed ID: 7773086
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG, Wagner W.
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [Abstract] [Full Text] [Related]

  • 9. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H, Kristek J, Heuer H, Bender F.
    Arzneimittelforschung; 1981 May; 31(9):1416-22. PubMed ID: 6118162
    [Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
    Abengowe CU.
    J Int Med Res; 1985 May; 13(2):116-21. PubMed ID: 2860041
    [Abstract] [Full Text] [Related]

  • 11. [Doppler echocardiography in assessing the effect of the beta 1-selective adrenoblocker acebutolol on left-ventricular diastolic filling in hypertension patients].
    Alekhin MN, Sedov VP, Bozh'ev AM, Sidorenko EA.
    Ter Arkh; 1997 May; 69(4):15-8. PubMed ID: 9213947
    [No Abstract] [Full Text] [Related]

  • 12. A cross-over trial comparing the effects of acebutolol and propranolol on the serum lipids and hypertension.
    Ghosh DC, Dutta S, Sarkar N.
    Indian Heart J; 1989 May; 41(5):292-5. PubMed ID: 2599537
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
    Whitsett TL, Levin DC, Manion CV.
    Chest; 1982 Dec; 82(6):668-73. PubMed ID: 6128186
    [Abstract] [Full Text] [Related]

  • 14. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N, Sugawara K, Ozaki M.
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [Abstract] [Full Text] [Related]

  • 15. Ancillary pharmacologic properties of acebutolol: cardioselectivity, partial agonist activity, and membrane-stabilizing activity.
    Giacomini JC, Thoden WR.
    Am Heart J; 1985 May; 109(5 Pt 2):1137-44. PubMed ID: 2859777
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacology of acebutolol in animals].
    Basil B.
    Nouv Presse Med; 1975 Dec 31; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [Abstract] [Full Text] [Related]

  • 17. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
    Silke B, Nelson GI, Verma SP, Ahuja RC, Okoli RC, Hussain M, Taylor SH.
    Herz; 1984 Feb 31; 9(1):57-64. PubMed ID: 6368345
    [Abstract] [Full Text] [Related]

  • 18. [Acebutolol in the therapy of mild and moderate hypertension].
    Widimský J.
    Vnitr Lek; 1994 Jan 31; 40(1):14-6. PubMed ID: 8140743
    [Abstract] [Full Text] [Related]

  • 19. Effects of equipotent blocking doses of acebutolol, acebutolol's primary metabolite, and propranolol on left ventricular hemodynamics in conscious awake dogs.
    Magder S, Rubenson D, Griffin G, Kernoff R, Harrison DC.
    J Cardiovasc Pharmacol; 1983 Jan 31; 5(4):691-6. PubMed ID: 6193369
    [Abstract] [Full Text] [Related]

  • 20. Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
    Tsukiyama H, Otsuka K, Horii M, Yoshii Y, Hatori Y, Nakamura Y, Nemoto E, Yamato T, Sakai T, Yamamoto Y.
    Jpn Circ J; 1983 Mar 31; 47(3):313-22. PubMed ID: 6132016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.